Bionik Laboratories Corp Share Price OTC Bulletin Board
Equities
US09074A1097
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Sales 2022 | 1.27M 106M | Sales 2023 | 1.81M 151M | Capitalization | 2.8M 233M |
---|---|---|---|---|---|
Net income 2022 | -10M -834M | Net income 2023 | -4M -334M | EV / Sales 2022 | 0.17 x |
Net cash position 2022 | 1.99M 166M | Net Debt 2023 | 1.98M 166M | EV / Sales 2023 | 2.65 x |
P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 44 | 30/20/30 |
Michal Prywata
FOU | Founder | 33 | 08/10/08 |
Dan Gonsalves
DFI | Director of Finance/CFO | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Prywata
FOU | Founder | 33 | 08/10/08 |
Director/Board Member | 68 | 01/17/01 | |
Richard Russo
CEO | Chief Executive Officer | 44 | 30/20/30 |
1st Jan change | Capi. | |
---|---|---|
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |